Skip to main content

Table 2 Characteristics of protein-bound uremic toxins

From: Removal of uremic toxins by renal replacement therapies: a review of current progress and future perspectives

Uremic toxins

Pre-dialysis concentrations (mg/dL)

Protein binding (%)

Reduction rate with hemodialysis (%)

Indoxyl sulfate

2.99 ± 0.18

97.7 ± 0.2

31.8 ± 1.4

Indoxyl glucuronide

0.25 ± 0.03

59.6 ± 1.5

79.6 ± 0.9

Indoleacetic acid

0.12 ± 0.01

94.1 ± 0.6

44.3 ± 1.5

P-Cresyl sulfate

3.71 ± 0.28

95.1 ± 0.6

29.1 ± 1.7

P-Cresyl glucuronide

0.58 ± 0.09

32.3 ± 2.6

80.7 ± 1.1

Phenyl sulfate

1.35 ± 0.15

90.7 ± 0.9

65.2 ± 1.4

Phenyl glucuronide

0.06 ± 0.01

76.1 ± 1.3

69.2 ± 8.6

Phenylacetic acid

0.05 ± 0.01

60.5 ± 2.4

35.0 ± 7.0

Phenylacethyl glutamine

4.15 ± 0.37

44.9 ± 2.1

75.7 ± 1.0

Hippuric acid

4.43 ± 0.53

48.3 ± 2.5

68.9 ± 1.6

4-Ethylphenyl sulfate

0.0242 ± 0.0044

99.3 ± 0.1

5.5 ± 2.5

3-Carboxy-4-methyl-5-propyl-2-furanpropionic acid

2.11 ± 0.13

99.7 ± 0.1

−30.5 ± 3.1

  1. Serum samples were obtained from patients undergoing maintenance hemodialysis whose Kt/V and protein-catabolic rate were 1.40 ± 0.03 and 0.97 ± 0.02 g/kg/day, respectively